Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
chronic kidney disease 2 nephrologydiseases
nephrotic syndrome 1 nephrologydiseases

There are not enough annotations found in this document to create the proximity graph.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
chronic kidney disease 40857 and the avoidance of their generation.Figure 1Main modifications of lipoprotein metabolism induced by chronic kidney disease (CKD). CKD induces a deep modification in lipoprotein metabolism resulting in the accumulation of pro-atherogenic
chronic kidney disease 43376 Abbreviations: refer to abbreviation section.Figure 3Main effects of oxidized lipids and lipoproteins in chronic kidney disease (CKD). CKD is associated with increased oxidative stress, which promotes covalent modifications of lipids
nephrotic syndrome 18842 levels in ESRD patients as its generation is not increased in these patients. Unlike hemodialysis, nephrotic syndrome exhibits enhanced secretion of Lp(a) by the liver [[110]]. In a nutshell, CKD exhibits higher levels

You must be authorized to submit a review.